These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 15173703)

  • 1. Modulating the pulmonary circulation: an update.
    Dembinski R; Henzler D; Rossaint R
    Minerva Anestesiol; 2004 Apr; 70(4):239-43. PubMed ID: 15173703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pulmonary hypertension with selective pulmonary vasodilators.
    Haj RM; Cinco JE; Mazer CD
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):88-95. PubMed ID: 16547439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhaled vasodilators].
    Zwissler B
    Anaesthesist; 2002 Aug; 51(8):603-24. PubMed ID: 12391520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective pulmonary vasodilation in acute respiratory distress syndrome.
    Kaisers U; Busch T; Deja M; Donaubauer B; Falke KJ
    Crit Care Med; 2003 Apr; 31(4 Suppl):S337-42. PubMed ID: 12682462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are inhaled vasodilators useful in acute lung injury and acute respiratory distress syndrome?
    Siobal MS; Hess DR
    Respir Care; 2010 Feb; 55(2):144-57; discussion 157-61. PubMed ID: 20105341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular pathophysiology and therapy of pulmonary hypertension.
    Olschewski H; Rose F; Grünig E; Ghofrani HA; Walmrath D; Schulz R; Schermuly R; Grimminger F; Seeger W
    J Lab Clin Med; 2001 Dec; 138(6):367-77. PubMed ID: 11753283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
    Adnot S; Samoyeau R; Weitzenblum E
    Blood Press Suppl; 1995; 3():47-57. PubMed ID: 8535542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heart pathology of extracardiac origin. IV. Pulmonary hypertension in chronic respiratory diseases].
    Barberà JA
    Rev Esp Cardiol; 1998 Jan; 51(1):56-68. PubMed ID: 9522610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
    Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacology of the pulmonary circulation].
    Follath F
    Schweiz Med Wochenschr; 1985 Sep; 115(39):1328-32. PubMed ID: 2866581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
    Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
    Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary vasodilators--treating the right ventricle.
    Granton J; Moric J
    Anesthesiol Clin; 2008 Jun; 26(2):337-53, vii. PubMed ID: 18456218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing pulmonary hypertension in heart transplantation: meeting the challenge.
    Coe PF
    Crit Care Nurse; 2000 Apr; 20(2):22-8; quiz 29-30. PubMed ID: 11873750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
    Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
    Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
    Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
    Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhalative strategies for improvement of pulmonary hemodynamics and gas exchange in sepsis and severe pulmonary hypertension].
    Grimminger F; Rose F; Ghofrani HA; Schermuly RT; Weissmann N; Olschewski H; Walmrath D; Seeger W
    Z Kardiol; 2000 Jun; 89(6):477-84. PubMed ID: 10929431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternatives to nitric oxide.
    Lowson SM
    Br Med Bull; 2004; 70():119-31. PubMed ID: 15531733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors.
    Schermuly RT; Inholte C; Ghofrani HA; Gall H; Weissmann N; Weidenbach A; Seeger W; Grimminger F
    Respir Res; 2005 Jul; 6(1):76. PubMed ID: 16033645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled nitric oxide combined with prostacyclin and adrenomedullin in acute respiratory failure with pulmonary hypertension in piglets.
    Dani C; Pavoni V; Corsini I; Longini M; Gori G; Giannesello L; Perna A; Gritti G; Paternostro F; Forestieri A; Buonocore G; Rubaltelli FF
    Pediatr Pulmonol; 2007 Nov; 42(11):1048-56. PubMed ID: 17902148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension.
    Fitzgerald RK; Oishi P; Ovadia B; Ross GA; Reinhartz O; Johengen MJ; Fineman JR
    Pediatr Crit Care Med; 2004 Nov; 5(6):571-7. PubMed ID: 15530195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.